Mots-clés
> MYOBASE > INFORMATION-COMMUNICATION > communication > événement > colloque
colloqueSynonyme(s)abstract ;acte de colloque ;conférence ;congrès ;journée ;séminaire ;work shop ;workshop ;rencontre symposium |
Documents disponibles dans cette catégorie (3074)
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Miles M ; Carlson CG | 2008Daily treatment of adult mdx mice with intraperitoneal injections of pyrrolidine dithiocarbamate (PDTC) substantially improved the resting membrane potential in severely dystrophic (mdx) triangularis sterni (TS) muscle fibers (Carlson et al., Ne[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Eisenberg I ; Eran A ; Lidov HG ; Kang PB ; Kohane IS ; Kunkel LM | 2008The muscular disorders are a heterogeneous group of over thirty different inherited diseases characterized by muscle wasting and progressive weakness of variable distribution and severity, resulting in significant morbidity and disability. Altho[...]Article
Distribution of ribonucleoprotein complexes in cajal bodies from SMA type i-derived fibroblast cells
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Renvoisé B ; Lefebvre S | 2008Spinal Muscular Atrophy (SMA) is a common neurodegenerative disease caused by reduced levels of the Survival Motor Neuron (SMN) protein. SMN is part of a large ubiquitous protein complex that concentrates in nuclear gems/Cajal bodies (CBs) and p[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Blumen SC ; Israeli D ; Robin V ; Astord S ; Barkats M ; Vignaud L ; Porte F ; Achiron A ; Carasso RL ; Gurevich M ; Braverman I ; Blumen N ; Viollet L | 2008Distal hereditary motor neuronopathies form a heterogeneous group of rare inherited lower motor neuron disorders. Autosomal recessive inheritance has been reported in six subtypes (dHMN III, IV, VI, Jerash type). We studied a large inbred Israel[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Guy-Coichard C | 2008A l'aube de la thérapie génique et des procédés curatifs spécifiques, la douleur dans les MNM reste peu évoquée et étudiée dans la littérature. Ce constat contraste avec le témoignage des malades et la pratique des soignants prenant en charge ce[...]Article
Trinh-Duc A ; Santin A ; Sureau C ; Bagou G ; Charpentier S ; Couvreur J ; Fougeras O ; Miranda J ; Philippe JM ; Perrier C ; Raphaël V ; Le Gall C | 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Berardinelli A ; Orcesi S ; Rossi M ; Motta C ; Gorni K ; Balottin U | 2008Duchenne muscular dystrophy (DMD) is an X-linked progressive neuromuscular disorder due to lack of Dystrophin protein in muscle. Dystrophin is mainly concentrated in skeletal and cardiac muscle and less in smooth muscle, its deficiency causing s[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Ferreiro V ; Giliberto F ; Muniz Garcia N ; Francipane L ; Marcese D ; Roque M ; Frechtel G ; Szijan I | 2008The severe Duchenne muscular dystrophy (DMD) and the milder Becker muscular dystrophy (BMD) are characterized by progressive muscular degeneration. Both are caused by mutations in the dystrophin gene (Xp21.2). Two thirds of patients show intrage[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sblendorio V ; Palmieri B ; Ferrari A ; Pietrobelli A | 2008Abstract. Duchenne muscular dystrophy yields pervasive and progressive muscle mass loss. In the current measures relating to the monitoring of disease progression is relevant: 1) the type of scale used; 2) the clinical significance of the at[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bitoun M ; Prudhon B ; Durieux AC ; Bevilacqua JA ; Romero NB ; Guicheney P | 2008The autosomal dominant centronuclear myopathy (CNM) is a rare congenital myopathy characterized by delayed motor milestones, facial and muscular weakness often associated with bilateral ptosis. The typical muscle histopathology comprises central[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Benard R ; Dupas B ; Tadayoni R ; Sene A ; Roux MJ ; Nudel U ; Yaffe D ; Sahel JA ; Rendon A | 2008Dp71 is the most abundant Duchenne Muscular Dystrophy (DMD) gene product expressed in the retina. This protein in the Müller glial cells (MGC) plays a role in regulating the retinal homeostasis by clustering Kir4.1 and AQP4 channels. (see poster[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Avril-Delplanque A ; Mercier S ; Daoud F ; Nusbaum P ; Leturcq F ; Kaplan JC ; Dreyfus P ; Chelly J ; Garcia L | 2008Duchenne Muscular Dystrophy (DMD) is the most severe form of dystrophinopathy, in which nul mutations in the DMD gene (mostly frameshifting deletions, and nonsense point mutations) result in the complete absence of dystrophin. A milder phenotype[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Desguerre I ; Poron F ; Barbet P ; Gherardi R ; Christov C | 2008In DMD, repeated cycles of acute myofiber necrosis and regeneration progressively lead to severe terminal myofiber degeneration and extensive fibrosis. A preliminary analysis of 39 muscle biopsies from DMD patients at different ages allowed roug[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Eagle M ; Scott E | 2008Le réseau North Star Clinical Network for Paediatric Neuromuscular Disease Management (NSCN) est une collaboration entre centres neuromusculaires du Royaume-Uni dont l'objectif est d'optimiser la prise en charge des enfants atteints de troubles [...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Finkel R | 2008L'échelle idéale pour l'évaluation d'un patient atteint d'un trouble neuromusculaire intègre des éléments significatifs du point de vue fonctionnel, peut être mise en œuvre rapidement et sans équipement onéreux, par des évaluateurs formés, est s[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Mercuri E | 2008Au cours des années passées, l'intérêt pour les échelles fonctionnelles et les autres méthodes d'évaluation de la fonction musculaire et de la force dans les troubles neuromusculaires n'a cessé d'augmenter. Une gamme de bonnes méthodes de mesure[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pandya S ; Fox D ; Ciafaloni E ; Druschel C ; Moxley R | 2008Objective : To determine the effect of age at initiation of corticosteroids on age at loss of ambulation in patients with Duchenne muscular dystrophy (DMD) Background : The hypothesis among clinicians is that earlier the initiation of corticoste[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Briguet A ; Erb M ; Courdier-Fruh I ; Barzaghi P ; Santos G ; Herzner H ; Lescop C ; Siendt H ; Henneboehle M ; Weyermann P ; Magyar J ; Dubach-Powell J ; Metz G ; Meier T | 2008Dystrophin deficiency is the underlying molecular cause of progressive muscle weakness observed in Duchenne muscular dystrophy (DMD). Loss of functional dystrophin leads to elevated levels of intracellular Ca2+, a key step in the cellular pathol[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rauscent H ; Bérard C ; Humbertclaude V ; Gautheron V ; Richelme C | 2008Concerning multidisciplinary care of Duchenne Muscular Dystophy (DMD), the prevention of scoliosis remains a priority. Spinal surgery is considered as the treatment of choice and early instrumentation and fusion are widely proposed. The objectiv[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Rosemblatt M ; Yu H ; de la Porte S | 2008INTRODUCTION A strategy for treating Duchenne muscular dystrophy (DMD) is to compensate for the absence of dystrophin by up-regulation of utrophin, a homologous cytoskeletal protein. OBJECTIFS One potential approach to up-regulate utrophin expre[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Turin E ; Hoff H ; Gatti F ; Winders T ; Singh R ; Starke J ; Rutter J ; Bledsoe C ; Lavin J ; Palmieri B ; Carlson CG | 2008Ursodeoxycholic acid (UDCA) is in current clinical use for the treatment of biliary cirrhosis and has been shown to reduce nuclear p65 activation in HeLa cells expressing elevated glucocorticoid receptor (Miura et al., J. Biol. Chem., 276(50), 4[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Jamart C ; An GL ; Francaux M ; Raymackers JM | 2008INTRODUCTION Des situations physiologiques et pathologiques entraînent la mise en décharge du muscle et provoquent perte de poids et de fonctionnalité. Le système ubiquitine-protéasome semble jouer un rôle dans ces modifications. OBJECTIFS Nous [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Steffensen B ; Mayhew A ; Aloysius A ; Eagle M ; Mercuri E ; Messina S ; Mazzone E ; Nadeau A ; Main M ; Scott E ; Werlauff U ; Werge B ; Glanzmann A ; Muntoni F | 2008The EK scale was developed as a clinical tool to assess functional ability and to determine the need for and impact of intervention in the non-ambulatory stages of Duchenne muscular dystrophy (DMD) and in spinal muscular atrophy (SMA). EK is a c[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Steffensen BF ; Mayhew A | 2008L'échelle EK a d'abord été développée comme outil clinique d'évaluation de la capacité fonctionnelle, pour déterminer la nécessité d'une intervention et évaluer les résultats de l'intervention chez des personnes atteintes de la dystrophie muscul[...]Article
Livre
Pereon Y, Auteur ; Magistris MR ; Raharijaona M ; Houlgatte R ; Camdessanché JP ; Attarian S ; Pouget J ; Viala K ; Magy L ; Danziger N ; Cassim F ; Boutry N ; Bouche P ; Séror R ; Baron D ; Psimaras P ; Ebelin M ; Truffert A ; Kurth I ; Libbrecht D ; Wang FC ; Mussini JM ; Pitt M ; Renault F ; Pereon Y ; Valls-Solé J ; Fournier E ; Labarre-Vila A ; Jabre JF ; Labat JJ ; Riant T ; Rigaud J ; Lefaucheur JP ; Raint R ; Guérineau M ; Robert R ; Maisonobe T ; Léger JM ; Larue S ; Dashi F ; Musset L ; Neil J ; Caillon F ; Magot A ; Soichot P ; Chauplannaz G ; Vial C ; Ochsner F ; Novy J ; Kuntzer T ; Nicolas G ; Petiot P ; Demeret S | Solal | 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Nivet AL ; Plancheron A ; Lustremant C ; Peschanski M ; Monville C | 2008Duchenne muscular dystrophy (DMD) is a genetic disease with an X-linked recessive pattern of inheritance. It affects one in 3,500 boys at birth. Muscular dystrophies are caused by mutation of the same gene encoding for the dystrophin. This prote[...]Rapport institutionnel
Article
Le premier Colloque "Défi de civilisation" sur le thème : "le handicap, enjeu de civilisation ?" s'est déroulé le 3 décembre 2007 au musée du quai Branly à Paris. Au programme : Trois tables rondes se sont réunies sur les sujets suivants : - L'h[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Pasalidou P ; Richelme C ; Destombe S ; Triolo V ; Hardion M | 2008INTRODUCTION L'enfant atteint de maladie neuromusculaire est particulièrement exposé au risque de dénutrition. Très peu d'études se sont intéressées à leur état nutritionnel. OBJECTIFS Évaluation de la dénutrition chez les enfants atteints de ma[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Doglio L ; Pernigotti I ; Tacchino C ; Pedemonte M ; Scapolan S ; Minetti C | 2008DMD patients walk with a non-physiological pattern showing a initially weakness of antigravitary muscles, followed by loss of walking capability. Initially, DMD patients do not show clinical signs of pathological pattern, that become manifest wi[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Belicchi M ; Meregalli M ; Razini P ; Cattaneo A ; Farini A ; Iacchetti E ; Porretti L ; Milani P ; Bresolin N ; Torrente Y | 2008The use of stem cells in regenerative medicine and cell-based therapies offers immense potential in diseases witch have currently no treatment such as Duchenne muscular dystrophy. A limitation to the use of CD133+ for a therapeutic application i[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Rahbek J | 2008La plupart des cliniciens, chercheurs, avocats de la santé, responsables politiques, et même les tiers payants sont d'accord - d'un point de vue conceptuel - pour dire que la mesure de la QdV est une considération importante dans l'évaluation de[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rahbek J | 2008Most clinicians, researchers, health care advocates, policy makers, and even third-party payers agree - on a conceptual level - that the measurement of QoL is an important consideration in evaluating the effectiveness of medical rehabilitation i[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Chopard A ; Bronicki L ; Hillock S ; Lunde J ; Jasmin BJ | 2008Several transcriptional mechanisms are known to be involved in the atrophic-hypertrophic response of skeletal muscle. However, converging lines of evidence have led us to hypothesize that post-transcriptional events, operating at the level of mR[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Daniele N ; Laure L ; Suel-Petat L ; Roudaut C ; Ouali A ; Bartoli M ; Richard I | 2008INTRODUCTION Les dystrophies musculaires sont des maladies génétiques caractérisées par une dégénérescence musculaire progressive. L'atrophie fréquemment associée à ces pathologies participe à la perte de force du tissu musculaire. OBJECTIFS Not[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Gallais B | 2008La fatigue est une plainte psychophysiologique fréquemment exprimée dans les pathologies neuromusculaires. Que ce soit dans sa dimension physiologique ou sa dimension subjective, la fatigue doit être évaluée et prise en compte par les rééducateu[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Millet GY ; Féasson L | 2008La fatigue figure parmi les symptômes les plus fréquemment revendiqués lors d'une première consultation neuromusculaire, cependant son origine et les mécanismes responsables de son apparition sont particulièrement diversifiés. Ce phénomène psych[...]Livre
Ce colloque organisé en partenariat avec l'Association Française contre les Myopathies (AFM) et la Caisse Nationale de Solidarité pour l'Autonomie (CNSA) aborde en première partie les connaissances socio-historiques et épidémiologiques sur les u[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sakthivel M ; Lakshmi R ; Thilothammal N ; Viswanathan V | 2008A 10-year-old female child presented with 2-year history of progressive difficulty in walking and getting up from supine posture. Clinical evaluation, serum creatine phosphokinase levels (2222 IU/L) and muscle biopsy was consistent with muscular[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Baranov VS ; Vakharlovsky VG ; Komantzev V ; Malysheva OV ; Kiselev AV | 2008The results of prolonged valproic acid (VA) treatment of 13 patients affected with proximal spinal muscular atrophy (SMA) are summarized. Positive clinical response was registered in 10 out of 13 SMA patients. Some minor clinical progress was re[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sene A ; Fort PE ; Forster V ; Mornet D ; Nudel U ; Yaffe D ; Sahel JA ; Rendon A | 2008We have showed that Dp71 and Utrophin are the only dystrophin superfamily members expressed in Müller Glial cells (MGC). Dp71 deletion leads to a compensating utrophin up-regulation Here we characterized the Dp71 or Utrophin /Dystrophin Associat[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Gautheron V | 2008An assessment of functional capacity is essential before starting any rehabilitation treatment and is a prerequisite if compensatory strategies and technical aids are to be suggested to patients. The Functional Independence Measure (FIM™) was pu[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Fleischmann BK | 2008We have assessed in recent years the utility of different types of progenitors/stem cells for cardiac repair after myocardial infarction. One of the key questions was whether infarcted heart tissue can determine the differentiation fate of engra[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Burghes A ; Workman E ; McGovern V ; Saieva L ; Pellizzoni L ; Beattie C | 2008Spinal muscular atrophy is caused by loss or mutation of the SMN1 gene and retention of SMN2, leading to low levels of functional SMN. A major function of SMN is assembly of the heptameric Sm ring onto snRNA with SMA tissues having reduced activ[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Junion G ; Bataillé L ; Jagla T ; Da Ponte JP ; Tapin R ; Jagla K | 2008Correct diversification of cell types during development is controlled by combinatorial code of transcription factor activities, the identity gene code. The role of identity genes in specifying cell fates has been demonstrated in a broad range o[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Apostol P ; Cimponeriu D ; Toma M ; Butoianu N ; Burloiu C ; Craiu D ; Magureanu S ; Gavrila L | 2008Vitamin D is a steroid hormone known for its key roles in calcium homeostasis, proliferation and apoptosis. Previous studies have also reported the association of vitamin D deficiency with muscle weakness and neuromuscular dysfunction. The vitam[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Melki J | 2008Motor neuron diseases (MND) are rare diseases characterized by degeneration of lower (spinal muscular atrophy, SMA), upper (spastic paraplegia, HSP and primary lateral sclerosis) or both upper and lower motor neurons (amyotrophic lateral scleros[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Basak AN | 2008ALS is the most common adult-onset motor neuron disease. Described in 1869, by the French Neurobiologist J. M. Charcot, the primary disease hallmark is the selective and progressive degeneration of the neurons in the corticospinal tracts. ALS pr[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Laing NG | 2008The congenital myopathies are a diverse group of entities, with considerable genetic heterogeneity. The genetic heterogeneity includes mutations in multiple different genes causing similar pathological phenotypes, and multiple different patholog[...]Article
Livre
Nuss M, Auteur ; Agthe C, Collaborateur ; Ancet P, Collaborateur ; De Vries N, Collaborateur ; Dreyer P, Collaborateur ; Fumagalli L, Collaborateur ; Gelly C, Collaborateur ; Griffo G, Collaborateur ; Parisot AS, Collaborateur ; Stiker HJ, Collaborateur ; Siegrist D, Collaborateur ; Stickel M, Collaborateur | Dunod | 2008Nos sociétés ont par rapport à la question de la sexualité des personnes handicapées une position paradoxale. Alors qu'on ne cesse de proclamer le droit des personnes dépendantes à l'égalité des chances dans tous les domaines, on peine encore à [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Belayew A | 2008Facioscapulohumeral muscular dystrophy (FSHD) is considered a disorder of gene regulation. The pathological deletions contract the D4Z4 repeat array in the 4q35 subtelomeric region from 11 -150 units in healthy individuals down to 1-10 units in [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Chien KR | 2008The heart is composed of diverse cell types: cardiac muscle, smooth muscle, conduction system, endothelial, valvular, and interstitial mesenchymal fibroblasts. Embryonic heart field precursors, marked by the expression of the isl1+ LIM homeodoma[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Peschanski M | 2008In a preliminary study published 8 years ago (Bachoud-Lévi et al., The Lancet 2000) we showed encouraging results of transplantations of foetal neuroblasts to the brain of patients with Huntington's Disease. Four out of the 5 grafted patients ex[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Acharjee S ; Friesen W ; Tomizawa Y ; Baiazitov R ; Lee S ; Nadarajan T ; Moon YC ; Sweeney L ; Welch EM | 2008PTC Therapeutics, Inc. (PTC) and Parent Project Muscular Dystrophy (PPMD) are collaborating to discover new drugs to treat Duchenne muscular dystrophy (DMD). Several targets were selected to enter the drug discovery program based on functional v[...]Article
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Maxim D ; Otelea D | 2008DMD and BMD are transmitted as an X-linked recessive traits. Risks include a family history of DMD and BMD. Bayesians’ analysis may be used antenatally when DNA testing is uninformative or inconclusive .We report the family cases where the affec[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Miranda R ; Sébrié C ; Degrouard J ; Jaillard D ; Laroche S ; Vaillend C | 2008Mdx mice provide a model of the human X-linked muscular dystrophy (DMD) caused by mutations in the DMD gene inducing absence of 427-KDa cytoskeletal protein dystrophin. Not only expressed in muscle fibers, dystrophin is also present in the posts[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Singh R ; Samadi A ; Carlson CG | 2008Although several reports indicate that dystrophic muscle exhibits elevated nuclear p65 activation, little is known regarding the disposition of the alternative pathway in dystrophic muscle. In nondystrophic muscle, several of the components of t[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Singh R ; Millman G ; Polisiakeiwicz L ; Turin E ; Sumski C ; Samadi A ; Carlson CG | 2008The development of more efficacious treatments for Duchenne and related muscular dystrophies would be facilitated by an improved understanding of the mechanism which promotes enhanced nuclear p65 activation in dystrophic skeletal muscle. To acco[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; André E ; Hodgkinso I ; Fontaine-Carbonnel S ; Vuillerot C ; Braillon P ; Bérard C | 2008INTRODUCTION Les corticostéroïdes (CS) entraînent habituellement une fonte musculaire et une adiposité. Ils sont cependant efficaces dans la dystrophie musculaire de Duchenne (DMD) pour améliorer la force musculaire. OBJECTIFS Afin de mieux comp[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Legendre C ; Noël M | 2008La notion d'interface sera ici considérée en tant que " dispositif permettant à une personne déficiente d'interagir avec son environnement ". En premier lieu, nous abordons ce qu'est, d'une façon générale, ce dispositif d'interaction que nous ap[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Di Giorgio F ; Carrasco M ; Siao MC ; Maniatis T ; Eggan K | 2008Here we report an in vitro model system to study the molecular and cellular mechanisms that underlie the neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS). Embryonic stem (ES) cells derived from mice carrying transgenic alleles of t[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mitchell KJ ; Sassoon D ; Marazzi G | 2008Non-satellite cells are known to possess myogenic potential and can participate in muscle regeneration, however, their precise position, origin and relationship to satellite cells remain unclear. During postnatal growth, PW1/Peg3, a gene co-expr[...]Article
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pinset C | 2008The general objective of cell therapy techniques is to replace population of deficient cells to restore the functions of damaged tissue due to disease or traumatism. Cell therapy technologies and methods have already beed developed for muscle di[...]Livre
Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Schabanel JC | 2008Préambule : La rééducation respiratoire instrumentale, si son apparition est ancienne (1975) il faut attendre les années 1998-2002 pour être reconnue. De plus son enseignement en France est encore très précaire par rapport à d'autres spé[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Beroud C ; Hamroun D ; Desmet FO ; Lalande M ; Tuffery-Giraud S ; Humbertclaude V ; Collod-Béroud G ; Claustres M | 2008The development of new genotype based therapeutic approaches has reinforced the interest about Locus Specific Databases (LSDB). This field is a crossroad of bioinformatics, genetics, clinics and research and many initiatives have been developed [...]Article
Laminopathies include a wide range of heterogeneous diseases involving different tissues, ranging from isolated peripheral neuropathies to systemic, premature aging diseases as Hutchinson-Gilford Progeria. Since the first involvement of the LMNA[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pouget J | 2008Amyotrophic Lateral Sclerosis (ALS) remains an intriguing neurodegenerative disorder and we do net yet understood its pathogenesis. The discovery of the Cu, Zn superoxyde dismutase gene (SOD1) mutation in 20% of familial cases dramatically modif[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bartoli M ; Gicquel E ; Barrault L ; Soheili T ; Malissen M ; Malissen B ; Udd B ; Danos O ; Richard I | 2008Limb girdle muscular dystrophy type 2D (LGMD2D, OMIM600119) is a genetic progressive myopathy that is caused by mutations in the human ?-sarcoglycan gene (SGCA). We introduced in mice the most prevalent LGMD2D mutation, R77C. Unexpectedly, we ob[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Worman HJ | 2008Cardiac disease is a prominent feature of Emery-Dreifuss muscular dystrophy (EDMD), with the initial presentation being atrioventricular conduction block followed by dilated cardiomyopathy. Autosomal dominant EDMD and related cardiomyopathies ar[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Freyssenet D | 2008La régulation de la masse musculaire est essentielle à l'homéostasie de l'organisme en permettant son adaptation à des contraintes environnementales, nutritionnelles ou pathologiques. La masse musculaire est largement régulée par des voies de si[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rose MR | 2008There are several motivations for the increasing interest in assessing quality of life (QoL) in chronic long term conditions such as neuromuscular disease (NMD). Many NMDs are not treatable, and even those that are may have persistent morbidity [...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Bérard C ; Payan C ; Groupe d'étude MFM | 2008Suite à l'envoi d'un questionnaire en 1998 à des équipes internationales quant au besoin d'une nouvelle échelle fonctionnelle adaptée aux maladies neuromusculaires, la Mesure de Fonction Motrice (MFM) été construite et validée. Trois versions su[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Gautheron V | 2008L'évaluation des capacités fonctionnelles est fondamentale pour la conduite des actes de rééducation-réadaptation, et indispensable pour la définition des moyens de compensation et des aides techniques à proposer aux patients. La Functional Inde[...]Livre
Article
Bérard C | 2008La Mesure de la Fonction Motrice (MFM) est validée pour estimer l’évolution des capacités motrices des patients atteints de maladies neuromusculaires. La MFM est traduite en plusieurs langues (français, espagnol, anglais et portugais). La MFM do[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Spitali P ; Fabris M ; Falzarano S ; Sabatelli P ; Bovolenta M ; Neri M ; Martoni E ; Tuffery-Giraud S ; Claustres M ; Cuisset J ; Gualandi F ; Rimessi P ; Ferlini A | 2008Exon skipping by antisense oligonucleotides (AONs) represents a promising tool successfully used for reframing dystrophin as demonstrated in a recent pilot trial in DMD patients. Since all the effort has been focused on favourable exons skipping[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Laporte J ; AlQusairi J ; Boehm J ; Buj Bello A ; Hnia K ; Jamet T ; Kretz C ; Nicot AS ; Tosch V ; Toussaint A ; Mandel JL | 2008Centronuclear (myotubular) myopathies (CNM) are characterized by muscle weakness and abnormal centralisation of nuclei in muscle fibres, which does not appear secondary to regeneration. The severe neonatal X-linked form (myotubular myopathy, XLC[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Saillour Y ; Mercier S ; Avril-Delplanque A ; Daoud F ; Nusbaum P ; Leturcq F ; Kaplan JC ; Dreyfus PA ; Cossee M ; Garcia L ; Bienvenu T ; Chelly J | 2008Duchenne Muscular Dystrophy (DMD) is the most severe form of dystrophinopathy, in which null mutations in the DMD gene (mostly frameshifting deletions, and nonsense point mutations) result in the complete absence of dystrophin. A milder phenotyp[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Benhassine T ; Hamadouche T ; Assami S ; Makri S ; Chaouch M ; Tazir M | 2008Proximal spinal muscular atrophy (SMA) are a group of motor neuropathies characterized by the degeneration of spinal montoneurons leading to muscular paralysis with muscular atrophy. They are the second most fatal autosomal recessive disease, wi[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Wan L ; Kasim M ; Wang C ; Cho S ; Bachorik J ; Cho Y ; Dreyfuss G | 2008The SMN complex, comprised of the survival of motor neurons (SMN) protein and the Gemins, plays a central role in cellular RNA metabolism. The SMN complex is essential in all cells and functions as a molecular assembly machine for the biogenesis[...]Article
The Pompe Disease Diagnostic Working Group ; Winchester B ; Bali D ; Bodamer OA ; Caillaud C ; Christensen E ; Cooper A ; Cupler EJ ; Deschauer M ; Fumic K ; Jackson M ; Kishnani P ; Lacerda L ; Ledvinova J ; Lugowska A ; Lukacs Z ; Maire I ; Mandel H ; Mengel E ; Muller Felber W ; Piraud M ; Reuser A ; Rupar T ; Sinigerska I ; Szlago M ; Verheijen F ; van Diggelen OP ; Wuyts B ; Zakharova E ; Keutzer J | 2008Accès au résumé PubMed / to PubMed abstractArticle
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sifi Y ; Sifi K ; Bestandji K ; Boulefkhad A ; Abadi N ; Benlatreche C ; Hamri A | 2008Introduction: Spinal muscular atrophy (SMA) is one of the most common autosomal recessive disorders, characterized by degeneration of anterior horn cells in the spinal cord, and leads to progressive muscular weakness and atrophy In the present s[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Tintignac LA ; Leibovitch SA ; Leibovitch MP ; Lagirand-Cantaloube J ; Csibi A ; Batonnet Pichon S | 2008INTRODUCTION The control of muscle cell size is balanced between protein synthesis and degradation. The muscle specific ubiquitine ligase Atrogin-1 is associated to pathology ranking from immobilisation, to sepsis, cancer and HIV. OBJECTIVE Atro[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Galan L ; Vela A ; Guerrero A ; Taxonera C ; Matias-Guiu J | 2008INTRODUCTION Inflammatory Bowel Disease (IBD) presents many neurological complications. Up to 3% of patients with IBD have neurological involvement (Thromboembolic phenomena, myelopathy, myopathy, multiple sclerosis and various neuropathies). Ju[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mouisel E ; Hourde C ; Vignaud A ; Butler Browne G ; Ferry A | 2008Aging results in a deterioration of muscle structure and function in dystrophic mdx mice lacking dystrophin. In the present study we wanted to know whether this aggravation is associated with an age related decline in regenerative capacity. Both[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vulin A ; Barthelemy I ; Goyenvalle A ; Lorain S ; Thibaud JL ; Bertoldi D ; Carlier P ; Dreyfus P ; Danos O ; Blot S ; Garcia L | 2008Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder due to mutations in the gene encoding dystrophin. Most of mutations consist in large deletions, although their size is not correlated with the severity of the phenotype. Out-of-[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vulin A ; Barthelemy I ; Dreyfus P ; Blot S ; Garcia L | 2008Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder due to mutations in the gene that encodes dystrophin. Most of these mutations consist in large genomic deletions, although their extent is not directly correlated with the sever[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Laurent E ; Borel P ; Hogrel JY ; Bousquet N ; Fougerousse F ; Stockholm D ; Calpain Study Group | 2008In the Natural History of Calpainopathies study (F Fougerousse's communication), 37 patients were subjected to Computed Tomography (CT) scans of lower limbs at the beginning of the investigation and 2 years later. The objective was to quantify m[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Graham K ; Singh R ; Millman G ; Malnassy G ; Berge J ; Gatti F ; Carlson CG | 2008Hydroxyproline assays were used to assess developmental changes in fibrosis in mdx and nondystrophic mice. In both adult nondystrophic and mdx mice, hydroxyproline levels (?g hydroxyproline/mg wet weight) were significantly higher in the costal [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Maciotta S ; Meregalli M ; Farini A ; Belicchi M ; Parolini D ; Bresolin N ; Torrente Y | 2008DMD is caused by frameshift mutations in the gene encoding for dystrophin. These mutations are responsible for the loss of function of the dystrophin protein that leads to membrane destabilization and subsequent activation of pathophysiological [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vilquin JT ; Marolleau JP ; Hagège A ; Larghero J ; Schwartz K ; Menasché P | 2008Cell grafting is a potential approach to improve cardiac healing and limit the progression of heart failure, which is characterized by a rapid and irreversible loss of cardiomyocytes. Many cell types have been tested. Myoblasts, being skeletal m[...]Livre
Vous pouvez consulter les "temps forts" du congrès et les posters sur le site de de Myology 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Oldfors O | 2008Myopathies which primarily affect the thick filament protein myosin may be hereditary or aquired. Hereditary myosin myopathies are a newly emerged group of diseases caused by mutations in skeletal muscle myosin heavy chain (MyHC) genes. The phen[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Chelh I ; Meunier B ; Picard B ; Reecy J ; Chevalier C ; Hocquette JF ; Cassar-Malek I | 2008Myostatin (MSTN), a member of the TGF-beta superfamily, is a negative regulator of skeletal muscle mass. Inactivating mutations of the MSTN gene are responsible for the development of a hypermuscular phenotype in mice (McPherron et al., 1997) an[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Urtizberea JA ; De Munain LA ; Mignard C ; Boué P ; Doppler V ; Hogrel JY ; Stockholm D ; Payan C ; Poza J ; Bousquet N ; Richard I ; Fougerousse F ; Calpain Study Group | 2008The determination of the natural history is a prerequisite to any future clinical trial in a given myopathy. This is particularly true in calpainopathy where the individual disease progression may markedly vary and where the course itself seems [...]